Higher chest wall dose results in improved locoregional outcome in patients receiving postmastectomy radiation

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages 1192-1199

  Panoff, Joseph E ^a   Takita, Cristiane ^a   Hurley, Judith ^a   Reis, Isildinha M ^a   Zhao, Wei ^a   Rodgers, Steven E ^a   Gunaseelan, Vijayalakshmi ^a   Wright, Jean L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Locoregional recurrence; Postmastectomy radiation; Radiation dose; Survival

Indexed keywords

BREAST CANCER; BREAST CONSERVATION; CHEST WALL; CLINICAL OUTCOME; CONFIDENCE INTERVAL; HAZARD RATIO; HIGH-RISK PATIENTS; LOCOREGIONAL CONTROL; LOCOREGIONAL RECURRENCE; LOW DOSE; MEDICAL RECORD; OVERALL SURVIVAL; POSTMASTECTOMY RADIATION THERAPIES; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RANDOMIZED TRIAL; SELECTION CRITERIA; SURVIVAL; TARGET VOLUMES;

DIAGNOSIS; DISEASES; PATIENT MONITORING;

RADIOTHERAPY;

ANTHRACYCLINE DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PLATINUM DERIVATIVE; TAXANE DERIVATIVE; TRASTUZUMAB;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; DOSIMETRY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HUMAN TISSUE; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; POSTMASTECTOMY RADIATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RACE DIFFERENCE; RADIATION DOSE; RETROSPECTIVE STUDY; THORAX WALL; TREATMENT OUTCOME;

BREAST NEOPLASMS; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THORACIC WALL; TREATMENT OUTCOME;

EID: 84856379742     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.02.045     Document Type: Article

References (26)

1. M. Overgaard, P.S. Hansen, and J. Overgaard Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial N Engl J Med 337 1997 949 955
2. M. Overgaard, M.B. Jensen, and J. Overgaard Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial Lancet 353 1999 1641 1648
3. J. Ragaz, I.A. Olivotto, and J.J. Spinelli Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial J Natl Cancer Inst 97 2005 116 126
4. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials Lancet 366 2005 2087 2106
5. M. Kyndi, M. Overgaard, and H.M. Nielsen High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c Radiother Oncol 90 2009 74 79
6. M. Kyndi, F.B. Sorensen, and H. Knudsen Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group J Clin Oncol 26 2008 1419 1426
7. Settle Amg-A SH, Buchholz TA, Woodward WA, Yu TK, Oh JL, Allen PK, Meric-Bernstam F, Hortobagyi HN, Tereffe W. Locoregional outcomes and radiotherapy response in patients with triple-negative breast cancer ASTRO. Chicago, IL; 2009.
8. E.H. Huang, S.L. Tucker, and E.A. Strom Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy J Clin Oncol 22 2004 4691 4699
9. H. Bartelink, J.C. Horiot, and P.M. Poortmans Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial J Clin Oncol 25 2007 3259 3265
10. P. Romestaing, Y. Lehingue, and C. Carrie Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France J Clin Oncol 15 1997 963 968
11. S.J. Feigenberg, N. Price Mendenhall, and R.K. Benda Postmastectomy radiotherapy: Patterns of recurrence and long-term disease control using electrons Int J Radiat Oncol Biol Phys 56 2003 716 725
12. S.E. McGuire, A.M. Gonzalez-Angulo, and E.H. Huang Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy Int J Radiat Oncol Biol Phys 68 2007 1004 1009
13. J.L. Wright, P.G. Cordeiro, and L. Ben-Porat Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage II-III breast cancer: Treatment intervals and clinical outcomes Int J Radiat Oncol Biol Phys 70 2008 43 50
14. M.M. Spierer, L.X. Hong, and R.T. Wagman Postmastectomy CT-based electron beam radiotherapy: Dosimetry, efficacy, and toxicity in 118 patients Int J Radiat Oncol Biol Phys 60 2004 1182 1189
15. R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
16. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, version 2.8.0 (2008-10-20). ISBN 3-900051-07-0. Available at: http://cran.r-project.org/doc/manuals/refman. pdf. Accessed: Date.
17. J.P. Fine, and GR A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
18. I.J. Bristol, W.A. Woodward, and E.A. Strom Locoregional treatment outcomes after multimodality management of inflammatory breast cancer Int J Radiat Oncol Biol Phys 72 2008 474 484
19. C. Polgar, J. Fodor, and Z. Orosz Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial Strahlenther Onkol 178 2002 615 623
20. V. Gebski, M. Lagleva, and A. Keech Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: A clinical perspective J Natl Cancer Inst 98 2006 26 38
21. M. Uematsu, B.A. Bornstein, and A. Recht Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer Int J Radiat Oncol Biol Phys 25 1993 765 770
22. G.M. Freedman, B.L. Fowble, and A.L. Hanlon Postmastectomy radiation and adjuvant systemic therapy: Outcomes in high-risk women with stage II-III breast cancer and assessment of clinical, pathologic, and treatment-related factors influencing local-regional control Breast J 3 1997 337 344
23. J.M. Metz, D.J. Schultz, and K. Fox Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence Cancer J Sci Am 5 1999 77 83
24. W.L. Donegan, C.M. Perez-Mesa, and F.R. Watson A biostatistical study of locally recurrent breast carcinoma Surg Gynecol Obstet 122 1966 529 540
25. F. Schwaibold, B.L. Fowble, and L.J. Solin The results of radiation therapy for isolated local regional recurrence after mastectomy Int J Radiat Oncol Biol Phys 21 1991 299 310
26. J. Willner, I.C. Kiricuta, and O. Kolbl Locoregional recurrence of breast cancer following mastectomy: Always a fatal event? Results of univariate and multivariate analysis Int J Radiat Oncol Biol Phys 37 1997 853 863